NYSE:COGlobal Cord Blood Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Global Cord Blood Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.53 +0.15 (+4.44 %) (As of 07/13/2020 01:14 PM ET) Add Compare Share Today's Range$3.40Now: $3.53▼$3.5350-Day Range$2.56MA: $2.94▼$3.3752-Week Range$2.54Now: $3.53▼$5.90Volume1,183 shsAverage Volume226,630 shsMarket Capitalization$429.07 millionP/E Ratio6.42Dividend YieldN/ABeta0.36 ProfileAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Global Cord Blood. Previous Next 2.6 Community Rank Outperform VotesGlobal Cord Blood has received 248 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGlobal Cord Blood has received 234 “underperform” votes. (Add your “underperform” vote.)Community SentimentGlobal Cord Blood has received 51.45% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Global Cord Blood and other stocks. Vote “Outperform” if you believe CO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldGlobal Cord Blood does not currently pay a dividend.Dividend GrowthGlobal Cord Blood does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Global Cord Blood insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 5.41% of the stock of Global Cord Blood is held by institutions. Previous Next 1.9 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Global Cord Blood is 6.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.92.Price to Earnings Ratio vs. SectorThe P/E ratio of Global Cord Blood is 6.42, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.48.Price to Book Value per Share RatioGlobal Cord Blood has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.90 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Holding & other investment offices Sub-IndustryN/A SectorMedical Current SymbolNYSE:CO Previous Symbol CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone852-3605-8180Debt Debt-to-Equity RatioN/A Current Ratio9.93 Quick Ratio9.85Price-To-Earnings Trailing P/E Ratio6.42 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$172.50 million Price / Sales2.49 Cash Flow$0.44 per share Price / Cash Flow8.03 Book Value$4.52 per share Price / Book0.78Profitability EPS (Most Recent Fiscal Year)N/A Net Income$66.48 million Net Margins38.57% Return on Equity12.64% Return on Assets6.72%Miscellaneous Employees1,261 Outstanding Shares121,550,000Market Cap$429.07 million Next Earnings Date8/25/2020 (Estimated) OptionableOptionable CO Rates by TradingView Receive CO News and Ratings via Email Sign-up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter. Global Cord Blood (NYSE:CO) Frequently Asked Questions How has Global Cord Blood's stock been impacted by COVID-19 (Coronavirus)? Global Cord Blood's stock was trading at $4.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CO shares have decreased by 13.3% and is now trading at $3.53. View which stocks have been most impacted by Coronavirus. When is Global Cord Blood's next earnings date? Global Cord Blood is scheduled to release its next quarterly earnings announcement on Tuesday, August 25th 2020. View our earnings forecast for Global Cord Blood. How were Global Cord Blood's earnings last quarter? Global Cord Blood Corp (NYSE:CO) issued its quarterly earnings data on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. Global Cord Blood had a return on equity of 12.64% and a net margin of 38.57%. View Global Cord Blood's earnings history. Has Global Cord Blood been receiving favorable news coverage? Media coverage about CO stock has trended very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Global Cord Blood earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Global Cord Blood. Are investors shorting Global Cord Blood? Global Cord Blood saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 26,500 shares, a decline of 30.6% from the June 15th total of 38,200 shares. Based on an average daily volume of 178,200 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the company's shares are short sold. View Global Cord Blood's Current Options Chain. Who are some of Global Cord Blood's key competitors? Some companies that are related to Global Cord Blood include Verra Mobility (VRRM), HL Acquisitions (LPRO), AdaptHealth (AHCO), NYSE:FEAC (FEAC), GS ACQUISITION /SH CL A (GSAH), Collier Creek (CCH), SOCIAL CAP HEDO/SH CL A (IPOB), Social Capital Hedosophia Holdings Corp. III (IPOC), Bain Capital Specialty Finance (BCSF), HAYMAKER ACQUIS/SH CL A (HYAC), Pure Acquisition (PACQ), FORUM MERGER II/SH CL A (FMCI), CF Finance Acquisition (CFFA), Leisure Acquisition (NEBU) and Gores Holdings III (GRSH). View all competitors. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), NovaBay Pharmaceuticals (NBY), Rite Aid (RAD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Galectin Therapeutics (GALT), Gilead Sciences (GILD), Intel (INTC) and Marvell Technology Group (MRVL). Who are Global Cord Blood's key executives? Global Cord Blood's management team includes the following people: Ms. Ting Zheng, Chairman, CEO & Interim CEO of Beijing Division (Age 47)Mr. Albert Chen, CFO & Director (Age 43)Ms. Xin Xu, Chief Technology Officer (Age 65)Ms. Rui Arashiyama, Chief Exec. Officer of Guangdong Division & Zhejiang Division (Age 60)Ms. Cathy Bai, VP of Corp. Fin. What is Global Cord Blood's stock symbol? Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO." How do I buy shares of Global Cord Blood? Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Global Cord Blood's stock price today? One share of CO stock can currently be purchased for approximately $3.53. How big of a company is Global Cord Blood? Global Cord Blood has a market capitalization of $429.07 million and generates $172.50 million in revenue each year. Global Cord Blood employs 1,261 workers across the globe. What is Global Cord Blood's official website? The official website for Global Cord Blood is www.globalcordbloodcorp.com. How can I contact Global Cord Blood? Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected] This page was last updated on 7/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
